Dr. Jonathan Jahr, MD

NPI: 1164466652
Total Payments
$392,368
2024 Payments
$545.42
Companies
10
Transactions
485

Payment Breakdown by Category

Other$291,220 (74.2%)
Travel$80,201 (20.4%)
Consulting$13,425 (3.4%)
Food & Beverage$7,522 (1.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $239,015 72 60.9%
Travel and Lodging $80,201 306 20.4%
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $45,000 13 11.5%
Consulting Fee $13,425 4 3.4%
Food and Beverage $7,522 85 1.9%
Honoraria $7,205 5 1.8%

Top Paying Companies

Company Total Records Latest Year
Merck Sharp & Dohme LLC $295,479 379 $0 (2023)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $64,543 71 $0 (2020)
BAUDAX BIO INC. $21,158 18 $0 (2022)
Bayer Healthcare LLC $5,750 2 $0 (2023)
Masimo Corporation $4,546 8 $0 (2021)
Octapharma USA, Inc. $607.34 2 $0 (2024)
Fresenius Kabi USA, LLC $83.40 2 $0 (2021)
Celgene Corporation $78.73 1 $0 (2017)
Heron Therapeutics, Inc. $77.51 1 $0 (2021)
VERTEX PHARMACEUTICALS INCORPORATED $45.42 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $545.42 2 Octapharma USA, Inc. ($500.00)
2023 $11,792 8 Merck Sharp & Dohme LLC ($6,042)
2022 $4,795 3 BAUDAX BIO INC. ($4,795)
2021 $10,775 15 Baudax Bio Inc. ($9,472)
2020 $34,735 47 Merck Sharp & Dohme Corporation ($23,126)
2019 $104,738 135 Merck Sharp & Dohme Corporation ($91,916)
2018 $138,882 166 Merck Sharp & Dohme Corporation ($89,460)
2017 $86,106 109 Merck Sharp & Dohme Corporation ($84,936)

All Payment Transactions

485 individual payment records from CMS Open Payments — Page 1 of 20

Date Company Product Nature Form Amount Type
10/28/2024 VERTEX PHARMACEUTICALS INCORPORATED Food and Beverage In-kind items and services $45.42 General
09/12/2024 Octapharma USA, Inc. BALFAXAR (Biological) Honoraria Cash or cash equivalent $500.00 General
Category: INTENSIVE CAREEMERGENCY
05/31/2023 Bayer Healthcare LLC Consulting Fee Cash or cash equivalent $2,875.00 General
05/24/2023 Bayer Healthcare LLC Consulting Fee Cash or cash equivalent $2,875.00 General
03/09/2023 Merck Sharp & Dohme LLC BRIDION (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,815.00 General
Category: NEUROSCIENCE
02/17/2023 Merck Sharp & Dohme LLC BRIDION (Drug) Travel and Lodging Cash or cash equivalent $150.00 General
Category: NEUROSCIENCE
02/15/2023 Merck Sharp & Dohme LLC BRIDION (Drug) Travel and Lodging In-kind items and services $965.94 General
Category: NEUROSCIENCE
02/15/2023 Merck Sharp & Dohme LLC BRIDION (Drug) Travel and Lodging In-kind items and services $821.13 General
Category: NEUROSCIENCE
02/15/2023 Merck Sharp & Dohme LLC BRIDION (Drug) Travel and Lodging In-kind items and services $182.96 General
Category: NEUROSCIENCE
02/15/2023 Merck Sharp & Dohme LLC BRIDION (Drug) Food and Beverage In-kind items and services $106.71 General
Category: NEUROSCIENCE
04/01/2022 BAUDAX BIO INC. ANJESO (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,400.00 General
Category: Pain Management
04/01/2022 BAUDAX BIO INC. ANJESO (Drug) Travel and Lodging Cash or cash equivalent $1,304.81 General
Category: Pain Management
02/10/2022 BAUDAX BIO INC. ANJESO (Drug) Food and Beverage In-kind items and services $89.97 General
Category: Pain Management
11/11/2021 Baudax Bio Inc. ANJESO (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,900.00 General
Category: Pain Management
11/11/2021 Baudax Bio Inc. ANJESO (Drug) Travel and Lodging Cash or cash equivalent $1,705.51 General
Category: Pain Management
11/11/2021 Heron Therapeutics, Inc. Zynrelef (Drug) Food and Beverage In-kind items and services $77.51 General
Category: Postoperative Pain
11/11/2021 Baudax Bio Inc. ANJESO (Drug) Food and Beverage In-kind items and services $39.16 General
Category: Pain Management
10/29/2021 Masimo Corporation SedLine (Device) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,000.00 General
Category: Devices
10/10/2021 Baudax Bio Inc. ANJESO (Drug) Food and Beverage In-kind items and services $110.71 General
Category: Pain Management
10/10/2021 Fresenius Kabi USA, LLC Food and Beverage In-kind items and services $41.70 General
10/10/2021 Fresenius Kabi USA, LLC Food and Beverage In-kind items and services $41.70 General
10/08/2021 Masimo Corporation EMMA and ISA (Device), rainbow Acoustic Monitoring, SedLine Food and Beverage In-kind items and services $142.50 General
Category: Devices
06/08/2021 Baudax Bio Inc. ANJESO (Drug) Food and Beverage In-kind items and services $85.76 General
Category: Pain Management
04/15/2021 Baudax Bio Inc. ANJESO (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,400.00 General
Category: Pain Management
04/15/2021 Baudax Bio Inc. ANJESO (Drug) Travel and Lodging Cash or cash equivalent $618.40 General
Category: Pain Management

About Dr. Jonathan Jahr, MD

Dr. Jonathan Jahr, MD is a Anesthesiology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164466652.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Jahr, MD has received a total of $392,368 in payments from pharmaceutical and medical device companies, with $545.42 received in 2024. These payments were reported across 485 transactions from 10 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($239,015).

Practice Information

  • Specialty Anesthesiology
  • Location Los Angeles, CA
  • Active Since 06/15/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 207L00000X
  • Entity Type Individual
  • NPI Number 1164466652

Products in Payments

  • BRIDION (Drug) $295,479
  • RELISTOR (Drug) $37,233
  • LUCEMYRA (Drug) $27,310
  • ANJESO (Drug) $21,158
  • SedLine (Device) $4,403
  • BALFAXAR (Biological) $500.00
  • EMMA and ISA (Device) $142.50
  • FIBRYGA (Biological) $107.34
  • Zynrelef (Drug) $77.51

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Anesthesiology Doctors in Los Angeles